Monday, August 28, 2017

Freenome Finds $7M More In Series A

South San Francisco-based Freenome said today that it has raised $7M more in its Series A funding, bringing its total raised for its disease screening company to $72M. the funding was led by Section 32, the venture firm led by former GV CEO Bill Maris, and also included Anne Wojcicki of 23andMe, along with other, un-named angels. The company, led by co-founder and CEO Gabe Otte, develops cancer and other disease screening tools. More information »